Patent Portfolio Strategy for Funded Technology Companies
A patent portfolio strategy is the plan that decides which of your inventions get filed, in what order, in which countries, and why. It's built around your funding timeline, your business model, and the questions your Board and investors will eventually ask. Having a strategy is different from simply filing patents as ideas come up.
What Is a Patent Portfolio Strategy?
A patent portfolio strategy is the deliberate plan behind a company's patent filings: which inventions to protect, in what sequence, in which locations, and how the resulting portfolio supports the business, not just the technology.
Most early-stage companies file their first patent reactively, often prompted by an investor question or an engineer's request. That single filing is useful, but it isn't a strategy. A patent strategy sets the criteria for what does and doesn’t get filed, decides how filing pace should track funding and revenue, and treats the portfolio as something a Board member or acquirer will eventually scrutinize, not just paperwork completed once and set aside.
For a funded technology company, the strategy question isn't whether to file it's what a filing program should look like once patents start functioning as a business asset that investors and acquirers price into their valuation.
Why It Matters Once You're Funded
Before funding, patent decisions are mostly about signaling: showing investors that the technology is defensible enough to bet on. After funding, the stakes change. A Board expects to see a plan, not a single filing. A later-round investor's technical diligence team will ask what is and isn’t protected, and why. An acquirer's counsel will run a freedom-to-operate check as a matter of course.
This is the point where an unstructured filing history becomes a liability. It is harder to explain gaps after the fact than it would have been to plan around them from the start. A founder trying to reconstruct the reasoning behind two years of ad hoc filings during a live diligence process is working from a weak position.
What a Patent Portfolio Strategy Involves
A working strategy covers several interdependent decisions, each of which affects the others. This is why they need to be planned together, rather than handled one filing at a time.
01.
Filing Roadmap Tied to Funding Stage
The right filing pace and coverage depend on how much capital the company has raised and what technical claims the business is actually making to investors. A filing roadmap places planned filings against expected fundraising milestones so the portfolio grows in step with the business, rather than falling behind it or overspending ahead of it.
02.
Defensive Protection vs. Licensing Positioning
Most technology companies build patents primarily as defensive protection in order to keep competitors from copying a product and to preserve freedom to operate. Some business models, particularly in semiconductor and hardware licensing, treat the patents themselves as the product, which considerably changes the filing volume and claim strategy. Getting this orientation right early on avoids restructuring a portfolio later at a real cost.
03.
Where to File: U.S., India, and Beyond
Filing everywhere is rarely the right answer, as is filing only where the company happens to be incorporated. The question is: where the company does business; where competitors operate; and where enforcement is realistically available. For companies with U.S. and India operations or go-to-market plans, that filing decision benefits from counsel who can evaluate both jurisdictions directly, rather than coordinating through a chain of local agents.
04.
Competitive Monitoring and Freedom to Operate
Submitting a patent filing doesn’t mean your company’s strategic plan is complete. Ongoing competitive intelligence, tracking what competitors are filing, and periodic freedom-to-operate reviews ensure your company isn’t building toward a product launch that ends up infringing upon an existing patent you didn't know about.
05.
AI and Software-Related Patentability
AI companies face patentability questions that didn't exist in the same form five years ago: what's actually patentable in a model-based product; how training data provenance and open-weight components affect defensibility; and what a Board needs to know in order to exercise credible oversight as the regulatory environment around AI keeps shifting. These aren't settled questions, and a strategy for an AI company has to be built with that uncertainty in mind, instead of treating it like a conventional software patent problem.
What Is a Patent Portfolio Strategy?
A patent portfolio strategy is the deliberate plan behind a company's patent filings: which inventions to protect, in what sequence, in which locations, and how the resulting portfolio supports the business, not just the technology.
Most early-stage companies file their first patent reactively, often prompted by an investor question or an engineer's request. That single filing is useful, but it isn't a strategy. A patent strategy sets the criteria for what does and doesn’t get filed, decides how filing pace should track funding and revenue, and treats the portfolio as something a Board member or acquirer will eventually scrutinize, not just paperwork completed once and set aside.
For a funded technology company, the strategy question isn't whether to file; it's what a filing program should look like once patents start functioning as a business asset that investors and acquirers price into their valuation.
Building the Portfolio by Funding Stage
How much strategizing a company needs to do, and what that strategy should prioritize, changes as the business matures. There's no fixed formula that applies to every company regardless of sector or capital raised; the right approach depends on the technology, the competitive picture, and how the company plans to use its funding. In general terms:
-
Pre-seed and seed: The priority is establishing a defensible starting position and demonstrating to early investors that IP thinking exists, even with a small portfolio.
-
Series A: Technical diligence tends to get more rigorous at this stage. Investors want to see a coherent filing rationale, not just a patent count, and a plan for how the company’s portfolio will grow in the next round.
-
Series B and beyond: The portfolio needs to hold up under real scrutiny, from later investors, potential acquirers, and, sometimes, litigation counterparties. This is typically when cross-border filing, licensing considerations, and formal Board reporting on intellectual property become part of the picture.
Talking strategy with counsel early in this progression is generally more useful than strategizing prompted by an urgent diligence request, because it leaves time to actually build the portfolio in the first place, rather than explain its gaps later on.
Common Challenges and Risk Points
-
Public disclosure timing: Demos, pitch decks, and product launches can start disclosure clocks that affect filing deadlines if they aren't tracked against the patent roadmap.
-
Budget versus coverage trade-offs: It's easy to either overspend on filings the business doesn't need yet, or underspend and leave core technology unprotected.
-
AI patentability uncertainty: Subject-matter eligibility and claim strategy for model-based inventions are still developing areas, which makes early guidance more valuable, not less.
-
Cross-border coordination: Managing U.S. and India filings (or additional markets) through disconnected local counsel tends to create inconsistent claim language and duplicated cost.
-
Diligence readiness: Portfolios built without an eye toward future scrutiny often require significant cleanup right before a raise or exit, exactly when there is the least time to do it.
How EVLG Helps
EVLG works with funded technology companies across AI infrastructure, semiconductor, photonics, robotics, defense, and electric vehicle sectors, with attorneys and technical specialists based in San Jose, California, and Bangalore. The firm has overseen more than 5,000 patent filings with an 87% grant rate, and its portfolios have contributed to more than $1.1 billion in combined client exit value, with IP accounting for an estimated 40-50% of deal value in those transactions.
​​
EVLG's Managing Shareholder, Kanika Radhakrishnan, is a Harvard-trained patent attorney, a former patent litigator at Morrison & Foerster, and an active startup investor who has backed more than 25 early-stage deep tech companies across the U.S., India, and Europe. That dual perspective, operator and investor, shapes how the firm builds portfolios: with an eye toward what will actually get scrutinized during a raise, not just what's patentable in the abstract.
​
For AI companies specifically, EVLG works directly on the questions the field is still resolving: what is patentable in a model-based product; how training data provenance and open-weight boundaries shape defensibility; and what a Board needs in order to exercise credible oversight as the regulatory environment moves. EVLG also serves as fractional IP counsel and advises Boards, technical committees, accelerators, incubators, and early-stage venture funds on IP defensibility ahead of financings and other events that trigger diligence.
Our Approach
-
Initial review of existing filings, technology, and competitive position
-
Freedom-to-operate and competitor context, so any filing decisions account for what's already out there
-
A filing roadmap aligned to funding stage, budget, and the questions your Board and investors are likely to ask
-
Prosecution and filing execution across the U.S., India, and any additional markets
-
Ongoing portfolio review so the company is diligence-ready ahead of its next raise, instead of scrambling
